Health Care & Life Sciences » Pharmaceuticals | Biomed-Lublin Wytwornia Surowic i Szczepionek

Biomed-Lublin Wytwornia Surowic i Szczepionek

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
Stock Exchange Warsaw Stock Exchange
EPS
 PLN0.5
Market Cap
 PLN62.26 M
Shares Outstanding
 62.26 M
Public Float
 -

Profile

Address
ul. Uniwersytecka 10
Lublin LU 20
Poland
Employees -
Website http://www.biomed.lublin.pl
Updated 07/08/2019
Biomed-Lublin Wytwornia Surowic I Szczepionek SA engages in the manufacture of pharmaceutical products. Its products include prescription and over-the-counter medicines, medical devices and laboratory reagents. The company was founded on December 4, 1944 and is headquartered in Lublin, Poland.

Financials

View All
Created with Highcharts 5.0.14Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.Net Income. Fiscal year is January-December. All values PLN Thousands.97997911511537 24237 24225 80425 80458858832 41232 412201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.Sales/Revenue. Fiscal year is January-December. All values PLN Thousands.32 97732 97733 57633 57642 58842 58836 33936 33931 40431 40432 29332 293201320142015201620172018010k20k30k40k50k

Jaroslaw Blaszczak
Chairman-Supervisory Board
Joanna Szymañska-Bulska
Member-Supervisory Board
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.